Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Open in API
Filings indexed 648 across all filing types
Latest filing 2017-06-24 Legal Proceedings Report
Country SE Sweden
Listing ST GETI

About Getinge

https://www.getinge.com/int/

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
Utredning av brasilianska konkurrensmyndigheten omfattar även två av Getinges brasilianska dotterbolag
Legal Proceedings Report Classification · 99% confidence The document is a short announcement dated June 24, 2017, detailing that two of Getinge's Brazilian subsidiaries are being investigated by the Brazilian competition authority (CADE) for alleged cartel formation related to medical equipment sales. The text explicitly states that this information is information that Getinge AB is obliged to make public under the EU's Market Abuse Regulation (MAR). This type of specific, material, non-financial regulatory disclosure that doesn't fit into standard financial report categories (like 10-K, ER, or IR) is best classified as a general regulatory announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for mandatory disclosures under MAR that are not otherwise specified, although 'Legal Proceedings Report' (LTR) is also a possibility due to the investigation. However, RNS is often used for MAR disclosures that are not specifically about dividends, insider trading, or capital changes. Since it is a formal, mandatory public disclosure under EU regulation, RNS is the best fit as a general regulatory filing notice.
2017-06-24 Swedish
Getinge plans guaranteed rights issue of approximately SEK 4 billion
Capital/Financing Update Classification · 98% confidence The document is a press release announcing that Getinge is planning a guaranteed rights issue of approximately SEK 4 billion to strengthen its balance sheet. This action involves issuing new shares to existing shareholders, which falls directly under the definition of a capital/financing activity. The key phrases are 'Getinge plans guaranteed rights issue' and 'propose that an Extraordinary General Meeting authorizes the Board to resolve on a new share issue with preferential rights'. This aligns perfectly with the 'Capital/Financing Update' category (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV); it is a specific announcement about raising capital via equity.
2017-06-14 English
Getinge planerar garanterad företrädesemission om cirka 4 Mdr SEK
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that Getinge plans a rights issue (nyemission) of approximately 4 billion SEK to strengthen its balance sheet and reduce leverage. This action involves raising capital through the issuance of new shares to existing shareholders, which directly relates to the company's capital structure and financing activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it mentions a conference call, the primary focus and substance of the document is the capital raise plan, not just the announcement of a report (RPA) or a general regulatory filing (RNS).
2017-06-14 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–March 2017. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management analysis of business performance, regional results, and operational updates. It is not an announcement of a report (RPA) nor a simple regulatory filing (RNS), as it provides the substantive financial data and analysis required for an Interim/Quarterly Report. Q1 2017
2017-04-25 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' and covers the period 'January – March 2017'. It contains detailed financial statements, including order intake, net sales, EBITA, cash flow, and balance sheet data, along with management commentary on performance and business operations. It is a comprehensive quarterly financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). Q1 2017
2017-04-25 English
Chief Financial Officer leaves Getinge
Board/Management Information Classification · 98% confidence The document explicitly announces that the Chief Financial Officer (CFO) of Getinge AB has decided to leave the company and specifies the timeline for his departure (remaining until November 2017). This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management. The document is short and contains a clear announcement, making MANG the most appropriate classification.
2017-04-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.